Fycompa and Movicol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fycompa (perampanel) and Movicol (polyethylene glycol 3350). Common drug interactions include urinary retention among females and dysphagia among males.

The phase IV clinical study analyzes what interactions people have when they take Fycompa and Movicol. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Fycompa?

Fycompa has active ingredients of perampanel. eHealthMe is studying from 4,387 Fycompa users. Check the latest studies of Fycompa.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

On Jul, 14, 2026

13 people who take Fycompa and Movicol together, and have interactions are studied.

What are the common drug interactions of Fycompa and Movicol, by gender? *:

female:

Urinary retention (the inability to completely or partially empty the bladder)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Haematuria (presence of blood in urine)
Respiratory failure (inadequate gas exchange by the respiratory system)
Cell death
Toxic skin eruption (skin breakdown due to toxic substance)
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)

male:

Dysphagia (a condition in which swallowing is difficult or painful)
Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
Decreased appetite
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
Influenza
Somnolence (a state of near-sleep, a strong desire for sleep)

What are the common drug interactions of Fycompa and Movicol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
Urinary retention (the inability to completely or partially empty the bladder)

10-19:

Decreased appetite
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Influenza
Somnolence (a state of near-sleep, a strong desire for sleep)
Dysphagia (a condition in which swallowing is difficult or painful)
Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)

20-29:

Cell death
Toxic skin eruption (skin breakdown due to toxic substance)

30-39:

n/a

40-49:

n/a

50-59:

Extrapyramidal disorder (involuntary muscle spasms in the face and neck)

60+:

Encephalopathy (functioning of the brain is affected by some agent or condition)
Haematuria (presence of blood in urine)
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 12 people, 92.31%
Partial Seizures (seizures which affect only a part of the brain at onset): 4 people, 30.77%
Pain: 4 people, 30.77%
Nausea (feeling of having an urge to vomit): 4 people, 30.77%
Headache (pain in head): 4 people, 30.77%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
High Blood Pressure: 1 person, 7.69%
Gastritis - Chronic (long lasting inflammation of stomach): 1 person, 7.69%
Embolic Stroke (stroke due to obstruction due to an embolus): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Fycompa and Movicol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously